End-of-day quote
Korea S.E.
03:30:00 08/05/2024 am IST
|
5-day change
|
1st Jan Change
|
6,110
KRW
|
-2.24%
|
|
-4.98%
|
+65.14%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
---|
Capitalization
1 |
14,40,309
|
3,07,059
|
2,45,547
|
Enterprise Value (EV)
1 |
14,60,950
|
2,02,123
|
1,65,470
|
P/E ratio
|
-7.92
x
|
-5.72
x
|
11.1
x
|
Yield
|
-
|
-
|
-
|
Capitalization / Revenue
|
57
x
|
7.26
x
|
3.03
x
|
EV / Revenue
|
57.9
x
|
4.78
x
|
2.04
x
|
EV / EBITDA
|
-176
x
|
-40.5
x
|
11.7
x
|
EV / FCF
|
-
|
-87,79,752
x
|
-25,46,32,267
x
|
FCF Yield
|
-
|
-0%
|
-0%
|
Price to Book
|
27.6
x
|
1.67
x
|
1.17
x
|
Nbr of stocks (in thousands)
|
51,532
|
66,034
|
66,364
|
Reference price
2 |
27,950
|
4,650
|
3,700
|
Announcement Date
|
23/03/23
|
23/03/23
|
21/03/24
|
Fiscal Period: December |
2021
|
2022
|
2023
|
---|
Net sales
1 |
25,249
|
42,303
|
80,997
|
EBITDA
1 |
-8,290
|
-4,990
|
14,172
|
EBIT
1 |
-11,235
|
-10,097
|
6,046
|
Operating Margin
|
-44.5%
|
-23.87%
|
7.46%
|
Earnings before Tax (EBT)
1 |
-2,25,900
|
-45,853
|
17,711
|
Net income
1 |
-1,76,267
|
-44,705
|
25,686
|
Net margin
|
-698.13%
|
-105.68%
|
31.71%
|
EPS
2 |
-3,527
|
-812.7
|
334.0
|
Free Cash Flow
|
-
|
-23,021
|
-649.8
|
FCF margin
|
-
|
-54.42%
|
-0.8%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
Announcement Date
|
23/03/23
|
23/03/23
|
21/03/24
|
Fiscal Period: December |
2023 Q3
|
---|
Net sales
1 |
13.85
|
EBITDA
|
-
|
EBIT
|
-
|
Operating Margin
|
-
|
Earnings before Tax (EBT)
|
-
|
Net income
|
-
|
Net margin
|
-
|
EPS
|
-
|
Dividend per Share
|
-
|
Announcement Date
|
14/11/23
|
Fiscal Period: December |
2021
|
2022
|
2023
|
---|
Net Debt
1 |
20,641
|
-
|
-
|
Net Cash position
1 |
-
|
1,04,936
|
80,078
|
Leverage (Debt/EBITDA)
|
-2.49
x
|
-
|
-
|
Free Cash Flow
|
-
|
-23,021
|
-650
|
ROE (net income / shareholders' equity)
|
-
|
-37%
|
12.9%
|
ROA (Net income/ Total Assets)
|
-
|
-3.44%
|
1.61%
|
Assets
1 |
-
|
13,00,801
|
15,92,935
|
Book Value Per Share
2 |
1,014
|
2,786
|
3,157
|
Cash Flow per Share
2 |
642.0
|
1,727
|
1,030
|
Capex
1 |
8,143
|
18,057
|
8,236
|
Capex / Sales
|
32.25%
|
42.68%
|
10.17%
|
Announcement Date
|
23/03/23
|
23/03/23
|
21/03/24
|
|
1st Jan change
|
Capi.
|
---|
| +65.14% | 297M | | -3.35% | 88.91B | | +4.08% | 41.25B | | -15.09% | 31.99B | | +51.08% | 24.73B | | -15.13% | 15.54B | | -40.39% | 12.07B | | -8.63% | 12.05B | | -14.78% | 12.02B | | +6.22% | 8.84B |
Biopharmaceuticals
|